Yumanity Therapeutics plans to Pay Special Dividend from Proposed Asset Sale to Janssen and Merger with Kineta

(24/7 MARKET NEWS) – Yumanity Therapeutics, Inc. (Nasdaq: YMTX) Yumanity Therapeutics, Inc. (Nasdaq: YMTX) announced, this morning, that its Board of Directors declared a special dividend in range of $1.34 to $1.43 per share of Yumanity common stock, will be payable in cash on or before December 29, 2022, to stockholders of record at the close of business on December 15, 2022, in connection with the previously announced asset sale to Janssen Pharmaceutica NV and merger with Kineta, Inc.

Yumanity is trading at $1.75, up $0.03 (+1.74%), on over 400 thousand shares traded.

Its 52- week range is $0.95 to $3.99 1.87. Its next inflection points are $1.85, 1.89 and $1.92.

24/7 MARKET NEWS, INC Disclaimer

24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to www.247marketnews.com or https://www.247marketnews.com/terms-disclaimer/ for further information.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist